$MRCY

Ballhaus William L sold $15.7M of MRCY

Ballhaus William L (Chairman, President & CEO) sold 173,209 shares of MERCURY SYSTEMS INC (MRCY) at an average of $90.59 ($89.47–$93.51, $15.69M total) across 4 trades over 2026-08-21 to 2026-08-24.

Original reporting
SEC EDGAR · Ballhaus William L
Published Aug 25, 2026, 9:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 9:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRCY
Bearish
medium confidence
Mentioned
$MRCY
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRCYBearishMed
01

Why it matters

The sale reduces insider ownership, potentially affecting perception of insider alignment with shareholders.

02

Market read

Insider sell of $15.7M by CEO may influence short-term price action; watch for market reaction.

03

What to watch

No disclosed reason for sale; could be tax planning or personal liquidity needs.

Relevance 7/10Novelty 7/10Timing: post-market filing

Background

Form 4 filing discloses insider transactions; investors monitor for signals about management confidence.

Company-level read

Ticker impact

$MRCYBearishMedium confidence
Context

CEO William L. Ballhaus sold 173,209 shares for $15.7M, reducing his stake to 299,836 shares.

Expected impact

Possible short-term downside pressure; watch for price dip on volume.

Evidence & confidence

Large insider sale by top executive, but no accompanying negative news; market may interpret as neutral to slightly bearish.

Market effects

Minimal impact on broader tech sector; reflects individual insider activity.

Limited to US markets where MRCY trades.

Low

Counterpoint

Insider sell could be routine diversification; not necessarily a bearish signal.

Key entities

  • William L. Ballhaus

    Chairman, President & CEO of Mercury Systems Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRCYMedAI 8/10

Surging Bookings And Palantir AI Deal Might Change The Case For Investing In Mercury Systems (MRCY)

Mercury Systems (MRCY) reported a 7.8% revenue increase to $983.62M and a net loss of $29.67M for the year. Bookings nearly doubled, backlog rose to $1.90B, and it raised its long-term growth target. The company also partnered with Palantir on AI-focused factory operations. Analysts project $1.2B revenue and $122.3M earnings by 2029, a 17% upside from current prices.

$MRCYMedAI 8/10

Mercury Systems (MRCY) Is Sitting On A Record Pile Of Orders

Mercury Systems (MRCY) reported strong fiscal Q4 and full-year results, with bookings up 93% YoY and backlog exceeding $1.9B. Margins improved, but earnings declined. The company reduced debt and partnered with Palantir (PLTR) for AI-driven operations. Management expects fiscal 2027 to align order growth with earnings.

$MRCYHighAI 8/10

Mercury Systems (MRCY) Q4 2026 Earnings Call Transcript

Mercury Systems (MRCY) reported Q4 2026 earnings with record bookings of $660M, revenue of $290M, and EBITDA margin of 16.7%. The company increased its organic growth outlook for FY 2027, citing strong demand and execution. Key drivers include increased production volumes, new development programs, and defense budget tailwinds. The company also announced a strategic agreement with Palantir to enhance operations.

$MRCYMed

Why Mercury Systems Stock Is Sinking Today

Mercury Systems (MRCY) reported Q4 2026 revenue of $289.8M, beating estimates, and set a new quarterly sales record. However, shares fell 6.4% due to missed EPS estimates and margin contraction, with operating margin dropping to 5% from 8.6% YoY. The company's high valuation (70x forward earnings) also raised investor concerns.